Please login to the form below

Not currently logged in
Email:
Password:

QED Clinical Services sets up in India

The CRO's Ahmedabad-based subsidiary will be led by Ali Sajjad Bohra

UK-based contract research organisation QED Clinical Services has established operations in India to extend its clinical research reach across the Asia Pacific region.

The CRO's new Ahmedabad-based subsidiary will be led by Ali Sajjad Bohra, who previously served as Asia Pacific regional director for the clinical monitoring group of a large global CRO.

Bohra said: “India and Asia Pacific will continue to have focus and will remain key markets for the drug development activities for biopharmaceutical companies on account of a variety of benefits.

“With our in-depth experience and knowledge of the region, we are committed to provide customised, cost-efficient and high quality services to both global as well as local clients.”

QED Clinical Services India will conduct trials in India and act as a hub for QED's Asia Pacific operations to enhance working arrangements with its local partners across the region.

QED's CEO Thomas Ogorka said: “The creation of QED Clinical Services India means that we can better meet the global development needs of our sponsors by giving access to vast patient populations via regional experts on the ground.

“India continues to receive great focus as an emerging territory and QED's presence here means we can leverage its high-quality capabilities.”

22nd March 2012

Share

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Empowering Strategic Performance Ltd

OUR GOAL: To help clients Metamorph™ Science into Action that changes healthcare to improve the lives of patients. Empowering Strategic...

Latest intelligence

When is an agency not an agency?
The PR Week UK Top 150 Consultancies prompts anticipation and curiosity. But can a virtual collective of freelancers fairly be compared and ranked against conventional agencies?...
Why big pharma needs to be braver
The last few years have seen the pharmaceutical industry undergo a rapid metamorphosis in the face of unprecedented change, but communications are one area that still needs an injection of...
Leveraging Real-World Evidence for Cell and Gene Therapies
Regulators and reimbursement bodies are increasingly turning to real-world evidence (RWE) to understand the long-term value of drugs, in particular novel therapies. Here, Mariam Bibi, Senior Director, Global RWE at...